J M van Steekelenburg1, A van Weijnen2, L M H de Pont3, O D Vijlbrief4, C C Bommeljé2, J P Koopman2, B M Verbist5, H M Blom2, S Hammer3. 1. From the Departments of Radiology (J.M.v.S., L.M.H.d.P., S.H.) j.vansteekelenburg@hagaziekenhuis.nl. 2. Otorhinolaryngology (A.v.W., C.C.B., J.P.K., H.M.B.), Haga Teaching Hospital, The Hague, the Netherlands. 3. From the Departments of Radiology (J.M.v.S., L.M.H.d.P., S.H.). 4. Department of Radiology (O.D.V.), Ziekenhuis Groep Twente, Almelo, the Netherlands. 5. Department of Radiology (B.M.V.), Leiden University Medical Centre, Leiden, the Netherlands.
Abstract
BACKGROUND AND PURPOSE: Ménière disease is characterized by endolymphatic hydrops, whereas perilymphatic enhancement on MR imaging has been suggested to be of additional value in diagnosing Ménière disease. This study evaluates the presence of endolymphatic hydrops and perilymphatic enhancement in patients with Ménière disease and with other vertigo-associated inner ear pathology. MATERIALS AND METHODS: A 3D-FLAIR sequence 4 hours after intravenous gadolinium injection was performed to visualize the endolymph and perilymph in 220 patients suspected of having Ménière disease. Patients' ears were retrospectively categorized as having Ménière disease (probable or definite) or other vertigo-associated inner ear pathology not attributable to Ménière disease. Endolymphatic hydrops was evaluated using a visual classification system, and perilymphatic enhancement was scored both visually and quantitatively. RESULTS: Endolymphatic hydrops was present in 137 (91.9%) of the definite Ménière disease ears and in 9 (7.0%) of the ears with other vertigo-associated inner ear pathology (P < .001). The combination of endolymphatic hydrops and visually increased perilymphatic enhancement was present in 122 (81.9%) definite Ménière disease ears compared with 4 (3.1%) ears with other vertigo-associated inner ear pathology (P < .001). This combination increases the positive predictive value from 0.94 for endolymphatic hydrops and 0.91 for perilymphatic enhancement to 0.97. The addition of measured perilymphatic enhancement leads to a moderate decrease in sensitivity from 0.92 for endolymphatic hydrops to 0.86. CONCLUSIONS: The combination of perilymphatic enhancement and endolymphatic hydrops in patients suspected of having Ménière disease increases the positive predictive value in the diagnosis of definite Ménière disease.
BACKGROUND AND PURPOSE: Ménière disease is characterized by endolymphatic hydrops, whereas perilymphatic enhancement on MR imaging has been suggested to be of additional value in diagnosing Ménière disease. This study evaluates the presence of endolymphatic hydrops and perilymphatic enhancement in patients with Ménière disease and with other vertigo-associated inner ear pathology. MATERIALS AND METHODS: A 3D-FLAIR sequence 4 hours after intravenous gadolinium injection was performed to visualize the endolymph and perilymph in 220 patients suspected of having Ménière disease. Patients' ears were retrospectively categorized as having Ménière disease (probable or definite) or other vertigo-associated inner ear pathology not attributable to Ménière disease. Endolymphatic hydrops was evaluated using a visual classification system, and perilymphatic enhancement was scored both visually and quantitatively. RESULTS: Endolymphatic hydrops was present in 137 (91.9%) of the definite Ménière disease ears and in 9 (7.0%) of the ears with other vertigo-associated inner ear pathology (P < .001). The combination of endolymphatic hydrops and visually increased perilymphatic enhancement was present in 122 (81.9%) definite Ménière disease ears compared with 4 (3.1%) ears with other vertigo-associated inner ear pathology (P < .001). This combination increases the positive predictive value from 0.94 for endolymphatic hydrops and 0.91 for perilymphatic enhancement to 0.97. The addition of measured perilymphatic enhancement leads to a moderate decrease in sensitivity from 0.92 for endolymphatic hydrops to 0.86. CONCLUSIONS: The combination of perilymphatic enhancement and endolymphatic hydrops in patients suspected of having Ménière disease increases the positive predictive value in the diagnosis of definite Ménière disease.
Authors: M Yamazaki; S Naganawa; M Tagaya; H Kawai; M Ikeda; M Sone; M Teranishi; H Suzuki; T Nakashima Journal: AJNR Am J Neuroradiol Date: 2011-12-15 Impact factor: 3.825
Authors: Nadia L Samaha; Mohamad M Almasri; J Dixon Johns; Michael Hoa Journal: Curr Opin Otolaryngol Head Neck Surg Date: 2021-10-01 Impact factor: 1.814
Authors: Marc van Hoof; Raymond van de Berg; Marly F J A van der Lubbe; Akshayaa Vaidyanathan; Marjolein de Wit; Elske L van den Burg; Alida A Postma; Tjasse D Bruintjes; Monique A L Bilderbeek-Beckers; Patrick F M Dammeijer; Stephanie Vanden Bossche; Vincent Van Rompaey; Philippe Lambin Journal: Radiol Med Date: 2021-11-25 Impact factor: 3.469
Authors: Anja Bernaerts; Nick Janssen; Floris L Wuyts; Cathérine Blaivie; Robby Vanspauwen; Joost van Dinther; Andrzej Zarowski; Erwin Offeciers; Filip Deckers; Jan W Casselman; Bert De Foer Journal: Neuroradiology Date: 2022-02-12 Impact factor: 2.804